唯万密封（301161）公告，公司股东华轩基金计划自公告披露之日起十五个交易日后的三个月内，以集 中竞价方式减持公司股份95.7万股，即不超过公司总股本的0.7975%。减持期间内，公司如有派息、送 股、资本公积金转增股本、配股、股份回购注销等股份变动事项，拟减持股份数量、价格将相应进行调 整，但减持股份占公司总股本的比例不变。 ...

Summary of Key Points - The company Kent Co., Ltd. (301591) announced that several executives plan to reduce their shareholdings [1] - Vice President Xu Changxu intends to reduce his holdings by up to 400,000 shares, accounting for 0.4755% of the total share capital [1] - Vice President He Fuxiang plans to reduce his holdings by up to 324,000 shares, representing 0.3852% of the total share capital [1] - Vice President Lin Feng aims to reduce his holdings by up to 165,900 shares, which is 0.1972% of the total share capital [1] - Vice President Jin Yu intends to reduce his holdings by up to 116,600 shares, making up 0.1386% of the total share capital [1] - Vice President and Chief Financial Officer Sun Jiaqing plans to reduce his holdings by up to 20,000 shares, accounting for 0.0238% of the total share capital [1] - The total number of shares to be reduced by these five executives is up to 1,026,500 shares, which constitutes 1.2203% of the total share capital [1] - The method of reduction will be through centralized bidding, and the reduction period is set for three months starting from fifteen trading days after the announcement [1]

Group 1 - The company Century Hengtong (301428.SZ) announced that its shareholders, Lava New Opportunities and Lava New Era, plan to reduce their holdings by a total of no more than 1,953,966 shares within three months from the date of the announcement [1] - The planned reduction represents 2.00% of the company's total share capital after excluding shares held in the repurchase special securities account [1] - The reason for the reduction is stated as the shareholders' own funding needs [1]

Core Viewpoint - Anhui Huaren Health Pharmaceutical Co., Ltd. plans to acquire equity stakes in three pharmacy chains for a total of 327 million yuan, aiming to enhance its market share and brand influence in East China [1][2] Group 1: Acquisition Details - The company intends to purchase 46.01% of Fujian Yangzuo Huimin Pharmaceutical Chain Co., Ltd. for 133.4 million yuan, 46.01% of Fujian Haihua Pharmaceutical Chain Co., Ltd. for 125.1 million yuan, and 70.01% of Tonglu Yishengtang Pharmacy Chain Co., Ltd. for 68.3 million yuan [2] - The funding for the acquisitions will come from the company's own funds and a change in the use of part of the raised funds, with 130 million yuan allocated for the acquisitions if approved [2] Group 2: Financial Performance and Valuation - The estimated revenue and net profit for the acquired companies in 2024 are as follows: Yangzuo Huimin 294 million yuan revenue and 5.615 million yuan net profit, Haihua Pharmaceutical 270 million yuan revenue and 11.056 million yuan net profit, and Yishengtang 96.46 million yuan revenue and 0.264 million yuan net profit [3] - The valuation increase rates for the acquired companies are significant: Yangzuo Huimin at 892.79%, Haihua Pharmaceutical at 1029.4%, and Yishengtang at 2350.84% [3] Group 3: Growth and Expansion - Since its listing in March 2023, the company has conducted 22 asset purchase transactions totaling over 1 billion yuan, with major investments including 876 million yuan for five significant equity investments [4] - The company has expanded its store count significantly, adding 440 stores in 2024, with a total of 1,774 stores by the end of the year [6] Group 4: Shareholder Activity - Despite the company's growth, it has faced significant shareholder sell-offs, with major shareholders reducing their stakes, including Alibaba Health and Huatai Health [7][8] - The company has stated that these sell-offs are based on the shareholders' operational and financial needs, and management remains confident in the company's future [8]

2025.05. 22 5月22日晚间，沪深两市多家上市公司发布公告，以下是第一财经对一些重要公告的汇总，供投资者 参考。 【品大事】 宏创控股：拟635.18亿元购买宏拓实业100%股权 宏创控股(002379)披露重组报告书（草案），公司拟发行股份购买魏桥铝电等持有的山东宏拓实业 有限公司（简称"宏拓实业"）100%股权，交易作价为635.18亿元。宏拓实业是全球领先的铝产品制 造商，目前是全球最大的电解铝生产商之一。此次交易有助于公司从单一铝深加工业务向集电解铝、 氧化铝及铝深加工的全产业链业务于一体的公司转型。此次交易前，山东宏桥为公司控股股东，张 波、张红霞及张艳红为公司实控人。重组交易对方之一的魏桥铝电为山东宏桥的全资子公司。此次交 易完成后，公司的控股股东将变更为魏桥铝电，实控人未发生变更。 丽珠集团：拟约15.87亿元收购越南IMP公司64.81%股份 丽 珠 集 团 (000513) 公 告 ， 公 司 境 外 全 资 附 属 公 司 LIAN SGP 拟 收 购 越 南 上 市 公 司 Imexpharm Corporation（简称"IMP"）64.81%股份，拟支付的股权购买价格为57 ...

每经记者｜范芊芊 每经编辑｜马子卿 并购重组 健康元：丽珠集团拟15.87亿元收购越南IMP公司64.81%股权 健康元公告称，控股子公司丽珠集团之全资附属公司LIAN SGP拟以57308亿越南盾（折合人民币约 15.87亿元）收购越南上市公司IMP（Imexpharm Corporation）64.81%股份。交易完成后，标的公司将成 为健康元合并报表范围内的附属公司。 宏创控股：公司拟购买山东宏拓实业100%股权 大千生态公告称，公司股东安徽新华发行（集团）控股有限公司计划通过集中竞价、大宗交易方式减持 公司股票不超过407.16万股，不超过公司总股本的3%；副总经理王正安计划通过集中竞价方式减持公 司股票不超过41.08万股，减持比例不超过公司总股本的0.3%。 商络电子：持股5%以上股东谢丽拟减持不超过350万股 商络电子公告称，公司持股5%以上股东谢丽计划在公告披露日起15个交易日后的3个月内，通过集中竞 价交易或大宗交易方式减持其持有的不超过350万股公司股份，占剔除回购专用账户股份后公司总股本 的0.51%。 风险事项 舒泰神：公司多个在研项目属于创新型生物制品，相关在研项目正在推进中 舒泰神 ...

Group 1 - Daqian Ecology announced that shareholder Xinhua Publishing Group plans to reduce its stake by up to 4,071,600 shares, representing no more than 3% of the total share capital [2] - Vice President Wang Zheng'an intends to reduce his holdings by up to 410,798 shares, which is no more than 25% of his total holdings and approximately 0.3027% of the company's total share capital [2] - The reduction period is set from June 16, 2025, to September 15, 2025 [2] Group 2 - Sanofi's stock has experienced a significant increase, with a cumulative rise of over 30% in two consecutive trading days and over 100% in four consecutive trading days, indicating abnormal trading fluctuations [2] - The company has entered into a collaboration with Pfizer for the 707 project, which involves a dual-specific antibody product targeting PD-1 and VEGF, with uncertain sales milestone payments and royalties based on market conditions [2] - The actual receipt of sales milestone payments and royalties is subject to uncertainties related to drug demand, market competition, and sales channels [2] Group 3 - Xinhua Insurance announced a commitment to invest 10 billion yuan in the second phase of the Honghu Fund, which has a total fund size of 20 billion yuan [3] - The establishment of the fund is pending regulatory procedures, and the implementation timeline may vary [3] - Sany Heavy Industry has submitted an application for H-share issuance and listing on the Hong Kong Stock Exchange, with the application materials being subject to updates [3] Group 4 - Laisentongling's stock has seen a 33.17% increase over three consecutive trading days, with a turnover rate of 40.49%, indicating potential speculative trading [3] - The company confirmed that its main operations remain stable, with no significant changes in daily operations or major contracts signed recently [3] - The production costs and sales conditions are reported to be normal [3]

Group 1 - Major shareholder Xiaozhou Optoelectronics plans to reduce its holdings by up to 1.2528 million shares, accounting for 0.93% of the company's total share capital [1] - The reduction period is set from June 16, 2025, to September 15, 2025 [1] - The reason for the reduction is due to the funding needs of Xiaozhou Optoelectronics' shareholder Su Min Investment Junxin [1]

壹网壹创（300792）公告，持股5%以上股东张帆计划减持不超过592.36万股，占公司总股本的 2.5000%。董事卢华亮拟减持不超过124.27万股，占公司总股本的0.5245%。减持期间为2025年6月16日 至2025年9月15日，减持方式为集中竞价交易和/或大宗交易。 ...

江阴天龙重工机械有限公司(以下简称"天龙重工")持有公司股份1,180,000股，占公司总股本的1.14%； 陈江持有公司股份5,290,100股，占公司股份总额的5.12%。天龙重工和陈江为一致行动人，合计持有公 司6,470,100股，占公司股份总额的6.26%。 本次减持计划实施不会导致上市公司控制权发生变更。今年一季报显示，北京沃衍、陈江分别为德龙激 光第二、三大股东。 在减持期间内，北京沃衍及其一致行动人、天龙重工及其一致行动人将根据市场情况、自身资金需求等 因素自主决定是否实施本次股份减持计划，存在减持数量、减持时间及减持价格的不确定性，也存在是 否按期实施完成的不确定性。 中国经济网北京5月22日讯德龙激光(688170.SH)昨日晚间披露《关于持股5%以上股东及其一致行动人 减持股份计划公告》。 根据公告，因自身资金需求，股东北京沃衍投资中心(有限合伙)(以下简称"北京沃衍")及其一致行动人 拟通过集中竞价和大宗交易相结合的方式减持不超过3,100,800股公司股份，拟减持比例不超过公司当前 总股本的3%。其中拟采取集中竞价交易方式减持的，在任意连续90日内，减持股份的总数不得超过公 司股份总 ...